Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.9, 2004-09, pp. : 1159-1169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daptomycin - a new option for resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Daptomycin: a novel agent for Gram-positive infections

By Tally F.P. Zeckel M. Wasilewski M.M. Carini C. Berman C.L. Drusano G.L. Oleson F.B.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1223-1238

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin - a novel antibacterial in the fight against resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Newer developments in the treatment of Gram-positive infections

By Koomanachai Pornpan Crandon Jared L Nicolau David P

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2829-2843

Informa Healthcare

Access to resources Recommend Favorite

Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite